These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30787098)

  • 21. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
    De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
    Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
    Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
    Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach.
    Kumar V; Yin M; Ishida K; Salphati L; Hop CECA; Rowbottom C; Xiao G; Lai Y; Mathias A; Chu X; Humphreys WG; Liao M; Nerada Z; Szilvásy N; Heyward S; Unadkat JD
    Drug Metab Dispos; 2021 Feb; 49(2):159-168. PubMed ID: 33051248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.
    Matsunaga N; Fukuchi Y; Imawaka H; Tamai I
    Drug Metab Dispos; 2018 May; 46(5):680-691. PubMed ID: 29352067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
    Mitra P; Weinheimer S; Michalewicz M; Taub ME
    Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation.
    Kumar V; Salphati L; Hop CECA; Xiao G; Lai Y; Mathias A; Chu X; Humphreys WG; Liao M; Heyward S; Unadkat JD
    Drug Metab Dispos; 2019 Apr; 47(4):350-357. PubMed ID: 30622164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of hepatocytes to investigate drug uptake transporters.
    Maeda K; Sugiyama Y
    Methods Mol Biol; 2010; 640():327-53. PubMed ID: 20645061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers.
    Bonnaventure P; Cusin F; Pastor CM
    Drug Metab Dispos; 2019 Apr; 47(4):412-418. PubMed ID: 30674615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of in vitro-in vivo extrapolation of biliary clearance using an empirical scaling factor versus transport-based scaling factors in sandwich-cultured rat hepatocytes.
    Zou P; Liu X; Wong S; Feng MR; Liederer BM
    J Pharm Sci; 2013 Aug; 102(8):2837-50. PubMed ID: 23712819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.
    Li R; Barton HA; Varma MV
    Clin Pharmacokinet; 2014 Aug; 53(8):659-78. PubMed ID: 25056496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites.
    Li R; Bi YA; Vildhede A; Scialis RJ; Mathialagan S; Yang X; Marroquin LD; Lin J; Varma MVS
    Drug Metab Dispos; 2017 Jul; 45(7):737-747. PubMed ID: 28438781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters.
    Nozaki Y; Izumi S
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):56-70. PubMed ID: 31901416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Models of Drug Metabolism, Transporters, and Toxicity.
    Sawant-Basak A; Obach RS
    Drug Metab Dispos; 2018 Nov; 46(11):1556-1561. PubMed ID: 30333205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.
    Tess DA; Ryu S; Di L
    Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method.
    Di L; Atkinson K; Orozco CC; Funk C; Zhang H; McDonald TS; Tan B; Lin J; Chang C; Obach RS
    Drug Metab Dispos; 2013 Dec; 41(12):2018-23. PubMed ID: 23857891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1.
    Kimoto E; Vourvahis M; Scialis RJ; Eng H; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2019 May; 47(5):493-503. PubMed ID: 30862625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?
    Alluri RV; Li R; Varma MVS
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):387-401. PubMed ID: 32228316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.